Serving Clients Nationwide.
Schedule A Consultation
In the highly regulated world of healthcare marketing, drug and medical device companies must navigate a complex web of federal and state advertising laws. Drugs and medical devices are regulated by federal agencies, like the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC). By conducting a drug and device advertising review, your company can better protect its business interests.
Whether you’re promoting a prescription drug, an over-the-counter product, a new medical device, or a form of compounded therapy, your marketing materials must comply with strict FDA and FTC standards. Otherwise, you risk warning letters, enforcement actions, and reputational harm. With experienced professional support, you can preemptively address issues before they happen.
At Boesen & Snow Law, we work with manufacturers, pharmacies, telemedicine platforms, medical spas, and marketing teams on compliance reviews. In Fiscal Year 2024, the FDA conducted 951 domestic inspections of drugs and issued nearly 400 official action citations.
These citations can impact your business financially, legally, and reputationally. We can help you communicate your product and its purpose effectively to those who need it while minimizing legal exposure.
The team at Boesen & Snow Law can assist with several aspects of advertising compliance, from product development to the launch of your product. We can help with:
We can help ensure your promotional materials meet the FDA’s requirements under the Food, Drug, and Cosmetic Act (FDCA), including by ensuring the ad has:
We can also review labeling, websites, brochures, sales aids, and social media, along with other supplemental promotional materials.
For non-prescription drugs, dietary supplements, and devices, the FTC regulates advertising practices under a “reasonable consumer” standard. We offer guidance to make sure:
We partner with clients at all stages of product development and marketing, and can aid your business with:
We help teams understand their responsibilities under FDA and FTC rules through:
This support can help your company and employees be compliant and prepared for any potential issue.
We represent a wide range of clients, including:
It is important that your prescription drug, medical device, supplement, or non-prescription drug complies with the appropriate regulations. Failure to comply with FDA and FTC advertising regulations can result in:
Our team understands both the legal and commercial realities of promoting healthcare products. We can provide practical and business-minded advice that protects your reputation and keeps your campaigns compliant. By ensuring compliance, you can support your business’s future.
A: The Office of Prescription Drug Promotion (OPDP) reviews complaints about promotional violations. If a consumer thinks a prescription drug advertisement violates the FDA regulations, then they can submit a complaint to the OPDP. The OPDP also conducts surveillance and review of prescription drug advertisements for compliance and also makes sure the information is not misleading or false. The OPDP can send letters to companies regarding these violations.
A: Direct-to-consumer (DTC) advertising is legal in the United States, which is one of the very few countries where it is fully legal. However, there still are restrictions and requirements in the U.S. about the information included in DTC advertising. The FDA regulates DTC advertising, requiring that the product advertising be accurate, balanced, and truthful. The OPDP conducts research to determine the relevance and impact of DTC advertising and other advertising that is directed at healthcare providers.
A: Drug advertising can violate FDA regulations in many ways, including:
Some of these violations apply to specific types of DTC advertising.
A: There are many FDA guidelines for DTC advertising, and these guidelines also depend on the type of drug advertisement. A product claim ad is one that names a drug, describes what it treats, and explains the benefits and risks. It is required to tell you one approved use for the drug, the drug’s generic name, and all risks of using the drug. Other types of ads only give the most important risks.
If you need help with drug or device advertising compliance, we can review your materials, train your team, and help you avoid costly regulatory problems.
Reach out today to schedule a consultation.
Fields marked with an * are required